Gilead Issues a voluntary recall of one lot of Vistide Gilead Sciences announced it is voluntarily recalling lot B120217A of Vistide (cidofovir injection) to the user level due to the presence of particulate matter found in some vials of this lot. Effects from intravenous injection of product with particulate matter can vary depending on the amount of particulate matter injected into the patient, the size of the particles and the patientís underlying medical condition, and can be severe. Gilead is not currently aware of any complaint attributable to the particles.
News For GILD From The Last 14 Days
Check below for free stories on GILD the last two weeks.